These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3501703)

  • 1. In vitro susceptibility of Haemophilus influenzae to cefixime.
    Powell M; Williams JD
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1841-2. PubMed ID: 3501703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
    Mortensen JE; Himes SL
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1456-8. PubMed ID: 2386375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
    Kumar A; Kelly KJ
    Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
    Bergeron MG; Lavoie GY; Boucher FD
    J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
    Mendelman PM; Henritzy LL; Chaffin DO; Lent K; Smith AL; Stull TL; Wiley EA
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1878-82. PubMed ID: 2610499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
    García-Cobos S; Campos J; Lázaro E; Román F; Cercenado E; García-Rey C; Pérez-Vázquez M; Oteo J; de Abajo F
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
    Knapp CC; Sierra-Madero J; Washington JA
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1896-8. PubMed ID: 3245701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
    Jacobs MR; Bajaksouzian S
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):105-12. PubMed ID: 9294699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae.
    Jones RN; Erwin ME
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):596-7. PubMed ID: 1915406
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
    Yamada T; Yokota Y; Ikeda F; Mine Y; Kitada T
    Chemotherapy; 1992; 38(1):28-35. PubMed ID: 1618001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
    Nash DR; Flanagan C; Steele LC; Wallace RJ
    Antimicrob Agents Chemother; 1991 Jan; 35(1):192-4. PubMed ID: 1901696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
    Jorgensen JH; Doern GV; Thornsberry C; Preston DA; Redding JS; Maher LA; Tubert T
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):27-32. PubMed ID: 3259490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.